The Hospitalization Rate of Cerebral Venous Sinus Thrombosis before and during COVID-19 Pandemic Era: A Single-Center Retrospective Cohort Study

[1]  M. Anbardar,et al.  Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature , 2021, Journal of NeuroVirology.

[2]  B. Muller-Pebody,et al.  National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave , 2021, Clinical Microbiology and Infection.

[3]  S. Joshi,et al.  Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[4]  F. Abd-Allah,et al.  Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study , 2021, Cerebrovascular Diseases Extra.

[5]  J. Geddes,et al.  Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases , 2021, EClinicalMedicine.

[6]  S. Mayer,et al.  Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study , 2021, American Journal of Neuroradiology.

[7]  M. Heldner,et al.  Journal Club: Trends in Incidence and Epidemiologic Characteristics of Cerebral Venous Thrombosis in the United States , 2021, Neurology.

[8]  Noha El ouafi,et al.  Bilateral Pulmonary Embolism in Patients Recovered From Asymptomatic COVID-19 Infection , 2021, Cureus.

[9]  E. Schulte,et al.  Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: A systematic review and meta‐analysis , 2021, European journal of neurology.

[10]  M. Moradi-Lakeh,et al.  COVID-19 in Iran: What was done and what should be done , 2021, Medical Journal of the Islamic Republic of Iran.

[11]  M. Azarpazhooh,et al.  Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review , 2020, Journal of Neurology.

[12]  H. Dasenbrock,et al.  Cerebral Venous Sinus Thromboses in Patients with SARS-CoV-2 Infection: Three Cases and a Review of the Literature , 2020, Journal of Stroke and Cerebrovascular Diseases.

[13]  L. Piroth,et al.  How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed? , 2020, Médecine et Maladies Infectieuses.

[14]  F. Khorvash,et al.  Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series , 2020, Journal of the Neurological Sciences.

[15]  Á. Chamorro,et al.  Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry , 2020, International journal of stroke : official journal of the International Stroke Society.

[16]  J. Antel,et al.  Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic , 2020, Journal of the Neurological Sciences.

[17]  P. Ferroli,et al.  Long lasting hypercoagulability after subclinical COVID-19 , 2020, Journal of Thrombosis and Thrombolysis.

[18]  Jiming Zhang,et al.  Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis , 2020, Journal of medical virology.

[19]  S. Haseli,et al.  Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era , 2020, eNeurologicalSci.

[20]  L. Nayak,et al.  The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management , 2020, Thrombosis Research.

[21]  N. Weiss,et al.  Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19 , 2020, American Journal of Neuroradiology.

[22]  A. Radmanesh,et al.  Cerebral Venous Thrombosis Associated with COVID-19 , 2020, American Journal of Neuroradiology.

[23]  J. Bartholomew,et al.  Coagulopathy in COVID-19. , 2020, Cleveland Clinic journal of medicine.

[24]  H. Hemasian,et al.  First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case , 2020, Revue Neurologique.

[25]  L. McCullough,et al.  Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE) , 2020, Journal of Stroke and Cerebrovascular Diseases.

[26]  Jong S. Kim.  Coronavirus Disease 2019 and Stroke , 2020, Journal of stroke.

[27]  D. Gommers,et al.  Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis , 2020, Thrombosis Research.

[28]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[29]  G. Chowell,et al.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[30]  M. Wasay,et al.  Asian Study of Cerebral Venous Thrombosis. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[31]  N. Ashjazadeh,et al.  Changes in trend of cerebral venous sinus thrombosis , 2019, Iranian journal of neurology.

[32]  M. Punter,et al.  Diagnosis and management of cerebral venous thrombosis , 2018, Clinical medicine.

[33]  T. Kleinig,et al.  Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study , 2016, Stroke.

[34]  A. Pirdehghan,et al.  Thrombosis of the Cerebral Veins and Sinuses in Hamadan, West of Iran. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[35]  M. Aramideh,et al.  The Incidence of Cerebral Venous Thrombosis: A Cross-Sectional Study , 2012, Stroke.

[36]  Gustavo Saposnik,et al.  Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[37]  T. Ortel.  Acquired thrombotic risk factors in the critical care setting , 2010, Critical care medicine.

[38]  M. Saadatnia,et al.  Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation , 2007, Acta neurologica Scandinavica.

[39]  J. Ferro,et al.  Cerebral venous thrombosis: an update , 2007, The Lancet Neurology.

[40]  A. Kamal,et al.  Incidence and epidemiology of cerebral venous thrombosis. , 2006, JPMA. The Journal of the Pakistan Medical Association.

[41]  N. Ashjazadeh,et al.  The study of intermediate-term survival of the patients with cerebral venous sinus thrombosis , 2020 .

[42]  J. Ferro,et al.  Cerebral venous thrombosis. , 2017, Nature reviews. Neurology.

[43]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[44]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.